Birdwatch Note
2024-10-16 07:40:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
すでにヨーロッパでも申請され、審査は最終段階まで進んでいます。治験を行ったベトナムやアメリカ、他国でも開発が進められています。 レプリコンワクチンは16,100人以上のヒトで臨床試験がされており、安全性が確認されています。日本での認可が人体実験であるというのは誤りです。 https://www.meiji-seika-pharma.co.jp/meiji-rep/for-public/common/KOSTAIVE_QA.pdf Meiji Seika ファルマは、こういった不安を煽る内容のデマ情報について、公式アカウントなどで注意喚起を行っています。 https://x.com/Meiji_Seika_p/status/1846336570221384073
Written by 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1846367481398808583
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1846456047931896138
- noteId - 1846456047931896138
- participantId -
- noteAuthorParticipantId - 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2 Participant Details
- createdAtMillis - 1729064401978
- tweetId - 1846367481398808583
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- すでにヨーロッパでも申請され、審査は最終段階まで進んでいます。治験を行ったベトナムやアメリカ、他国でも開発が進められています。 レプリコンワクチンは16,100人以上のヒトで臨床試験がされており、安全性が確認されています。日本での認可が人体実験であるというのは誤りです。 https://www.meiji-seika-pharma.co.jp/meiji-rep/for-public/common/KOSTAIVE_QA.pdf Meiji Seika ファルマは、こういった不安を煽る内容のデマ情報について、公式アカウントなどで注意喚起を行っています。 https://x.com/Meiji_Seika_p/status/1846336570221384073
Note Ratings
| rated at | rated by | |
| 2024-10-18 01:09:17 -0500 | Rating Details | |
| 2024-10-18 00:58:16 -0500 | Rating Details | |
| 2024-10-18 00:55:43 -0500 | Rating Details | |
| 2024-10-18 00:48:43 -0500 | Rating Details | |
| 2024-10-18 00:37:24 -0500 | Rating Details | |
| 2024-10-18 00:33:07 -0500 | Rating Details | |
| 2024-10-18 00:31:30 -0500 | Rating Details | |
| 2024-10-17 21:02:33 -0500 | Rating Details | |
| 2024-10-16 22:24:01 -0500 | Rating Details | |
| 2024-10-16 21:32:31 -0500 | Rating Details | |
| 2024-10-16 21:20:55 -0500 | Rating Details | |
| 2024-10-16 19:29:11 -0500 | Rating Details | |
| 2024-10-16 17:04:38 -0500 | Rating Details | |
| 2024-10-16 15:19:01 -0500 | Rating Details | |
| 2024-10-16 14:21:15 -0500 | Rating Details | |
| 2024-10-16 08:03:41 -0500 | Rating Details | |
| 2024-10-16 04:21:54 -0500 | Rating Details | |
| 2024-10-16 04:13:11 -0500 | Rating Details | |
| 2024-10-16 03:35:19 -0500 | Rating Details | |
| 2024-10-16 03:25:42 -0500 | Rating Details | |
| 2024-10-16 03:14:14 -0500 | Rating Details | |
| 2024-10-16 03:02:14 -0500 | Rating Details | |
| 2024-10-16 03:00:35 -0500 | Rating Details | |
| 2024-10-16 02:56:58 -0500 | Rating Details | |
| 2024-10-16 02:54:42 -0500 | Rating Details | |
| 2024-10-27 20:57:57 -0500 | Rating Details | |
| 2024-10-18 04:49:06 -0500 | Rating Details | |
| 2024-10-18 01:23:27 -0500 | Rating Details | |
| 2024-10-18 01:21:03 -0500 | Rating Details | |
| 2024-10-18 00:36:28 -0500 | Rating Details | |
| 2024-10-17 02:00:37 -0500 | Rating Details | |
| 2024-10-17 00:05:47 -0500 | Rating Details | |
| 2024-10-16 10:22:09 -0500 | Rating Details | |
| 2024-10-16 08:53:12 -0500 | Rating Details | |
| 2024-10-16 08:47:34 -0500 | Rating Details | |
| 2024-10-16 08:27:32 -0500 | Rating Details | |
| 2024-10-16 07:35:45 -0500 | Rating Details | |
| 2024-10-16 07:34:43 -0500 | Rating Details | |
| 2024-10-16 06:47:53 -0500 | Rating Details | |
| 2024-10-16 06:04:57 -0500 | Rating Details | |
| 2024-10-16 05:54:45 -0500 | Rating Details | |
| 2024-10-16 05:34:14 -0500 | Rating Details | |
| 2024-10-16 03:05:28 -0500 | Rating Details | |
| 2024-10-16 03:02:19 -0500 | Rating Details | |
| 2024-10-16 03:00:51 -0500 | Rating Details | |
| 2024-10-16 02:53:37 -0500 | Rating Details | |
| 2024-10-16 02:47:40 -0500 | Rating Details |